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We  have  previously  reported  on the solvent  versatility  of  immobilized  amylose  and  cellulose-based  chi-
ral stationary  phases  in  enantioselective  liquid  chromatographic  separation  of  racemates.  The  studies
were mainly  focusing  on  the  tris  substituted  3,5-dimethylphenylcarbamate  polysaccharide-based  chiral
stationary  phases  namely  CHIRALPAK  IA® [Amylose  tris  (3,5-dimethylphenylcarbamate)]  or  ADMPC and
CHIRALPAK  IB® [Cellulose  tris  (3,5-dimethylphenylcarbamate)]  or CDMPC.  Here  we  focus  on the  applica-
tion  of  the  recently  introduced  amylose  tris  (3-chloro-5-methylphenylcarbamate)  or  ACMPC  and  brand
name  CHIRALPAK  IG® with  a chlorine  substituent  replacing  the  methyl  group  in CHIRALPAK  IA® . This
was  investigated  for  the  enantioslective  separation  of  different  classes  of pharmaceuticals  namely  - and
-blockers,  anti-inﬂammatory  and  antifungal  drugs,  norepinephrine-dopamine  reuptake  inhibitor,  cat-
echolamines,  sedative  hypnotics,  anti-histaminics,  anticancer  drugs,  antiarrhythmic  drugs,  ﬂavonoids,
amino  acids,  alpha-2  adrenergic  agonist,  adrenaline  and  miscellaneous.A  brief comparison  between  CHI-
RALPAK  IG® and CHIRALPAK  IA® under  normal  standard,  non-standard  and  reversed  mobile  phase  is
demonstrated.  The  results  revealed  the  versatility  of  the  CHIRALPAK  IG® column,  its  compatibility  with
a  wide  ranges  of solvent  and  operation  modes  and  its ability  to separate  chiral  compounds  not  separated
 chirwith  other  amylose  based
. Introduction
Many pharmaceutics and herbicides are chiral. They exist as two
ncongruent stereoisomers called enantiomers. As optical isomers,
hey rotate linearly polarized light in opposite directions although
hey are generally known to have similar physical properties (eg,
elting point, hydrophobicity, etc) and they can behave quite dif-
erently to one another in a chiral (asymmetric) environment. Since
iological processes tend to involve chiral chemicals (eg. enzymes),
hirality constitutes an important topic in drug development [1].
he United States Food and Drug Administration (FDA) requires
oxicology testing for racemates only, regardless of industry plans
o market a single isomer. In case of unexpected or signiﬁcant toxi-
ity is found in the racemate, FDA suggests querying the agency on
hether similar studies are required for individual enantiomers. In
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hexu.wang@canberra.edu.au (C. Wang).
ttps://doi.org/10.1016/j.chroma.2017.11.049
021-9673/© 2017 Elsevier B.V. All rights reserved.al stationary  phases.
© 2017  Elsevier  B.V.  All  rights  reserved.
such case, the FDA requires that only the active drug enantiomer
(the eutomer) is produced by an enantioselective access (e.g., via
asymmetric synthesis, resolution via diastereomers, kinetic reso-
lution, enzyme catalysis or chirality pool approach). The inactive
enantiomer (the distomer) constitutes ‘isomeric ballast’ or it may  be
highly toxic. In the case of thalidomide, one enantiomer possessed
the required therapeutic effect, while the other was eventually
shown to be teratogenic causing birth defects in the unborn babies.
While the use of enantiomerically pure drugs may appear to be
a viable solution to such a problem, conﬁgurationally unstable
stereoisomers like thalidomide may  interconvert (known variously
as enantiomerization, enantiomeric inversion or racemisation) [2].
The thalidomide tragedy was  entirely avoidable, had the physiolog-
ical properties of the individual thalidomide forms been identiﬁed,
separated and tested prior to commercialization.
Enantioselective chromatography has been well documented
as a powerful, contemporary and practical technique for the chi-
ral separation of racemic drugs, food additives, agrochemicals,
fragrances and chiral pollutants [1,2]. This technique is several
steps ahead of other previously reported methods to access pure
90 A. Ghanem, C. Wang / J. Chromatogr. A 1532 (2018) 89–97
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sFig. 1. Chemical structures of CHIRALPAK® am
nantiomers; including synthesis from a chirality pool, asym-
etric synthesis from pro-chiral substrates and the resolution of
acemic mixtures [3]. The separation of racemic mixtures has been
onsidered as the most feasible method for industrial applica-
ions compared to the time consuming and expensive synthetic
pproaches [4]. Remarkable developments have occurred in enan-
ioselective chromatography since the ﬁrst chiral separation of
nantiomers using optically active stationary phase in the mid-
ixties [5]. Following this development, several subclasses have
merged as well established chromatographic techniques with
utstanding applications in chiral separation like electrochro-
atography (EC), supercritical ﬂuid chromatography (SFC), counter
urrent chromatography (CCC), gas chromatography (GC), and high
erformance liquid chromatography (HPLC) [6]. The chiral selectors
sed as stationary phases in liquid chromatography play a cru-
ial role in the separation efﬁciency and the column backpressure
overning the entire separation [1].
Most enantioselective separations are performed by direct res-
lution using a chiral stationary phase (CSP) where the chiral
elector is adsorbed, attached, bound, encapsulated or immobi-
ized to an appropriate support to make a CSP. The enantiomers are
esolved by the formation of temporary diastereomeric complexes
etween the CSP and the analyte. Yet, thousands of CSPs have been
eported, with more than one hundred commercialized [7]. Among
he existing CSPs, those prepared from polysaccharides such as
ellulose and amylose, attract more attention due to their pow-
rful separation capability [8–18]. In general, the developments
f chemically post-modiﬁed polysaccharides are the mainstream
rend in the commercial and non-commercial chiral stationary
hases. Out of the commercially available polysaccharide-based
hiral stationary phases, cellulose and amylose were adsorbed,
onded, encapsulated or immobilized [19–26]. Of the amylose
erivatives, the coated tris (3,5-dimethylphenylcarbamate) known
s CHIRALPAK AD
®
has been widely and effectively used in
hiral separation. However, it is not compatible to all eluents
olvents, in particular, non-standard organic solvents such as
thyl acetate (EtOAc), tetrahydrofuran (THF), methyl tert-butyl
ther (MtBE), dichloromethane (DCM) and chloroform, in which
he polysaccharide derivatives can be dissolved or swollen. To
iden the selection of solvents, the polysaccharide derivatives
ave been immobilized/bonded onto a silica matrix and have
een extensively used as chiral stationary phases in non-standard
rganic solvents. Such immobilization of the polymeric chiral
elector is considered as an efﬁcient approach to confer a uni- and cellulose based chiral stationary phases.
versal solvent versatility [27–32]. Several immobilized phases
have been commercialized (Fig. 1). For examples CHIRALPAK
IA
®
: Amylose tris (3,5-dimethylphenylcarbamate); CHIRALPAK
IB
®
: Cellulose tris (3,5-dimethylphenylcarbamate); CHIRALPAK
IC
®
: Cellulose tris (3,5-dichlorophenylcarbamate); CHIRALPAK ID
®
:
Amylose tris (3-chlorophenylcarbamate); CHIRALPAK IE
®
: Amylose
tris (3,5-dichlorophenylcarbamate) and CHIRALPAK IF
®
: Amylose
tris (3-chloro-4-methylphenylcarbamate) have been extensively
studied and proved to be solvents versatile in the enantiomeric
separation of racemates [3,4]. Most recently CHIRALPAK IG
®
: Amy-
lose tris (3-chloro-5- methylphenylcarbamate) with a chlorine
substituent replacing the methyl group in CHIRALPAK IA
®
was
introduced. Here we  focus on the solvents versatility of CHIRAL-
PAK IG
®
and the enantioselective separations of racemates (Fig. 2)
under non-standard organic solvents and reversed phase chro-
matographic conditions. A brief comparison with CHIRALPAK IA
®
showing the effect of chlorine substituent in CHIRALPAK IG
®
on the
enantiomeric separation of racemates is also demonstrated.
2. Materials and methods
2.1. Instrumentation
Conventional HPLC analysis was  carried out using a Promi-
nence Shimadzu System that consists of an LC-20 AD VP pump
(Kyoto, Japan), SIL- 20AHT auto sampler, a GL Science UV–vis
detector model MU 701 UVVIS (Tokyo, Japan), and a Shimadzu
CDM-20A communications bus module (Kyoto, Japan). All analy-
ses were performed at room temperature. CHIRALPAK IG
®
(4.6 mm
ID × 250 mm,  5 m silica gel) was supplied by Daicel (Tokyo, Japan).
2.2. Chemicals and reagents
All solvents were HPLC grade purchased from Sigma-Aldrich (St.
Louis, MO,  USA). Most of the tested compounds (Fig. 2) were also
purchased from Sigma-Aldrich (St. Louis, MO,  USA) namely Pro-
pranolol 1, Naproxen 3, Flurbiprofen 4, Indoprofen 5, Miconazole
8, Nomifensine 10,  Arterenol 11,  Normetanephrine 12,  Ifosfamide
15,  Tocainide 16 Propafenone 17,  Glutamic acid monohydrate 20,
Tyrosin 21,  Phenylalanine 22,  -Methyl DOPA 23,  Epinephrine
24, 1-Acenaphthenol 25 and 4-Hydroxy-3-methoxymandelic acid
26.  On the hand, Naftopidil 2 was  purchased from Boehringer
Mannheim (Mannheim, Germany), Cizolirtine 6 was purchased
from American Custom Chemicals Corp., (San Diego, CA, USA),
romat
C
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arprofen 7 and Sulconazole 9 were purchased from AK Scientiﬁc
Union, CA, USA), Aminoglutethimide 13 was purchased from CIBA
EIGY (Basel, Switzerland), Chlorpheneramine 14 was  purchased
rom Research Biochemicals International (Natick, MA,  USA), Fla-
anone 18 and 6-Hydroxyﬂavanone 19 were purchased from Alfa
esar (Ward Hill, MA,  USA). 1-Indanol 27 was purchased from Fluka
hemical (Milwaukee, WI,  USA). 1-Phenyl-2,2,2-triﬂuorethanol 28
as purchased from Sigma-Aldrich Switzerland.
Classiﬁcation of the investigated racemates and their purities
re as listed below:
Classiﬁcation Durg Purity & Supplier
-blocker Propranolol 1 99%, Sigma-Aldrich, USA
-Blockers Naftopidil 2 NA, Sigma-Aldrich, USA
Anti-inﬂammatory
drugs
Naproxen 3 NA, Sigma-Aldrich, USA
Flurbiprofen 4 NA, Sigma-Aldrich, USA
Indoprofen 5 NA, Sigma-Aldrich, USA
Cizolirtine 6 NA, American Custom
Chemicals Corp., USA
Carprofen 7 98%, AK Scientiﬁc, USA
Antifungal drugs Miconazole 8 98% Sigma-Aldrich, USA
Sulconazole 9 NA, AK Scientiﬁc, USA
Norepinephrine-
dopamine reuptake
inhibitor
Nomifensine 10 NA, Sigma-Aldrich, USA
Catecholamines Arterenol 11 97%, Sigma-Aldrich, USA
Normetanephrine12 98%,  Sigma-Aldrich, USA
Sedative hypnotic Aminoglutethimide13 NA, CIBA GEIGY,
Switzerland
Anti-histaminic Chlorpheneramine14 NA, Research Biochemicals
International, USAAnticancer drug Ifosfamide 15 98%, Sigma-Aldrich, USA
Antiarrhythmic drugs Tocainide 16 98%, Sigma-Aldrich, USA
Propafenone 17 NA, Sigma-Aldrich, USA
Flavonoids Flavanone 18 98%, Alfa Aesar, USA
6-Hydroxyﬂavanone19 98%, Alfa Aesar, USA
Fig. 2. Chemical structures of a set of racemates investigated fogr. A 1532 (2018) 89–97 91
Amino acids Glutamic acid
monohydrate 20
98%, Sigma-Aldrich, USA
Tyrosin 21 99%, Sigma-Aldrich, USA
Phenylalanine 22 99%, Sigma-Aldrich, USA
Alpha-2 adrenergic
agonist
a-Methyl DOPA 23 NA, Sigma-Aldrich, USA
Adrenaline Epinephrine 24 NA, Sigma-Aldrich, USA
Miscellaneous 1-Acenaphthenol 25 99%, Sigma-Aldrich, USA
4-Hydroxy-3-
methoxymandelic acid
26
98%, Sigma-Aldrich, USA
1-Indanol 27 98%, Fluka Chemika, USA
1-Phenyl-2,2,2-
triﬂuorethanol
28
98%, Sigma-Aldrich,
Switzerland
2.3. Sample preparations
Stock solutions of the racemic analytes at concentrations of
1 mg/mL  in ﬁltered HPLC-grade 2-propanol were prepared, ﬁltered
through Sartorius Minisart RC 15 0.2-m pore size ﬁlters (Goettin-
gen, Germany) and further used for analysis without dilution; the
injection volume was 1 L.
2.4. HPLC conditions
The enantioselective analyses were conducted using standard
normal mobile phase comprised of n-hexane in combination with
2-propanol (2-PrOH) or ethanol (EtOH) and non-standard normal
phase namely tetrahydrofuran (THF), dichloromethane (DCM) and
methyl tert-butyl ether (MtBE). Reversed mobile phase consisted
of acetonitrile (ACN) and water (H2O) mixture. The additives TEA
and TFA were added in both normal and reversed mobile phases.
UV analyses were performed at ﬁxed wavelength (254 nm)  for all
compounds.
or their enantioselective separation on CHIRALPAK IG® .
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Fig. 3. UV traces/Chromatograms for the enantioselective separation of racemates
under normal standard and non-standard mobile phase.2 A. Ghanem, C. Wang / J. Ch
. Results and discussion
The well-known coated amylose tris (3,5-
imethylphenylcarbamate) ADMPC (CHIRALPAK AD
®
) in which
he amylose derivative is physically coated on 5 or 10 m silica
articles has been widely and effectively used in chiral separation
f racemates in high performance liquid chromatography. Its
mmobilized version namely CHIRALPAK IA
®
introduced ten years
go showed excellent solvent versatility and enantioselectivity
n normal standard and non-standard organic mobile phases
27–32]. More recently, this phase showed promising enantios-
lectivity under HILIC and reversed phase modes as well [33]. In
HIRALPAK IA
®
, the chiral selector is immobilized/bonded onto
 m silica particles. The replacement of one donating methyl
roup with a withdrawing chlorine substituent of the ADMPC has
esulted in the commercialization of a new immobilized phase
amely amylose tris (3-chloro-5-methylphenylcarbamate) known
s CHIRALPAK IG
®
or ACMPC. Here we demonstrate the solvent
ersatility and enantioselectivity of the new phase CHIRALPAK IG
®
nder normal standard and non-standard organic phase as well as
eversed phase chromatographic conditions. A brief comparison
ith CHIRALPAK IA
®
showing the effect of the donating methyl vs
ithdrawing chlorine substituent in amylose derivatives on the
nantioselectivity is brieﬂy demonstrated.
.1. Chiral separation under normal standard and non-standard
rganic mobile phase
The initial mobile phase selected for the enantioselective sepa-
ation of racemates 1–28 (Fig. 1) was a binary mixture of standard
rganic solvents consisting of n-hexane/ethanol screened from
0:10 to 10:90 v/v at 1 ml/min ﬂow rate on CHIRALPAK IG® at
xed UV detection 245 nm.  Out of the twenty eight compounds
creened, ﬁfteen compounds namely 1, 3–8,  10, 12, 14, 16–19 and
5–28 were baseline separated under either 90:10 or 80:20 v/v
-hexane/ethanol, respectively (Table 1 and Fig. 3). No baseline
eparation was achieved for 2, 9, 11,  13,  15 and 20–24. Replacing
thanol (EtOH) with 2-propanol (2-PrOH) resulted in the baseline
eparation of 4, 6, 7, 8, 10,  12,  16–19,  25 and 27 under either
0:10, 80:20, 70:30 or 60:40 v/v n-hexane/2-PrOH (Table 1). Com-
aring 2-PrOH with ethanol in mobile phase composition and in
erms of enantioselective separation, resolution Rs and separa-
ion factor , ethanol in mobile phase composition was superior
han 2-PrOH. Thus, 1, 3, 5, 14,  26 and 28 were all separated
nder n-hexane/ethanol which wasn’t the case in n-hexane/2-PrOH
mplying that ethanol works better with the 3-chloro substituted
mylose in amylose tris (3-chloro-5-methylphenylcarbamate) or
HIRALPAK IG
®
. It is noteworthy that the retention is generally
horter with ethanol than 2-PrOH or when using higher alco-
ol contents in relation to n-hexane in mobile phase composition
Table 2 and Fig. 3). To widen the choice of solvents in an attempt
o enhance the separation or resolve the unresolved compounds
nder standard solvents above; dichloromethane (DCM), tetrahy-
rofuran (THF) or methyl tert-butyl ether (MtBE) were used before
ombination with standard organic solvent. The addition of non-
tandard solvents in mobile phase composition enhanced the
esolution Rs and separation factor  of several tested racemates
Table 1). For example, in case of 6, the resolution Rs jumped from
s 1.47 and separation factor  1.38 in standard solvents namely
-hexane/2-PrOH 90:10 v/v, respectively and Rs 3.83 and  1.19
n n-hexane/EtOH 90:10 v/v to Rs 5.13 and separation factor 
.35 when using non-standard solvent in excess in mobile phase
omposition (MtBE 98% v) in combination with ethanol (EtOH 2%
) or MtBE/EtOH 98:2% v/v. Of particular interest, compound 11
hich wasn’t resolved under any standard solvents ‘combination
nvestigated in this study was baseline separated under excess of
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Table  1
The resolution Rs and separation factor  for the enantioselective separation of racemates under normal standard and non-standard mobile phase condition (Rs <1 = not
separated, Rs > 1 = separated.
IG Normal solvents Additives IA
Standard solvents Nonstandard solvents
Rs  n-Hexane 2-PrOH EtOH THF DCM MtBE TEA TFA Rs 
1 0.621 1.137 80 20 NS NS
1.202  1.152 90 10 NS NS
0.711  1.12 80 20 0.1 NS NS
0.278  1.12 80 20 0.1 NS NS
2  NS NS 90 10 0.31 1.18
3 1.243  1.122 80 20 NS NS
1.232  1.119 90 10 NS NS
3.196  1.236 80 20 0.1 NS NS
5.411  1.384 90 10 0.1 NS NS
1.745  1.091 80 20 0.1 NS NS
2.799  1.151 90 10 0.1 NS NS
0.678  1.149 80 20 NS NS
2.035  1.634 2 98 NS NS
4 2.341  1.129 90 10 NS NS
1.469  1.134 70 30 NS NS
2.434  1.125 90 10 0.1 NS NS
1.652  1.104 80 20 0.1 NS NS
1.367  1.054 60 40 0.1 NS NS
9.632  4.803 80 20 NS NS
10.05  1.597 90 10 NS NS
8.423  1.462 80 20 0.1 NS NS
8.214  1.533 80 20 0.1 NS NS
9.202  1.931 90 10 0.1 NS NS
0.798  1.132 80 20 NS NS
1.15  1.338 50 0.2 50 NS NS
5 3.361  1.497 80 20 0.1 NS NS
2.793  1.275 60 40 NS NS
1.413  1.347 2 98 NS NS
6 1.47  1.38 90 10 NS NS
2.361  1.134 80 20 0.1 NS NS
3.835  1.19 90 10 0.1 NS NS
5.131  3.354 2 98 NS NS
2.391  1.684 60 40 NS NS
7 0.897  1.141 90 10 NS NS
1.454  1.15 80 20 NS NS
0.399  1.121 80 20 0.1 NS NS
0.647  1.347 60 40 0.1 NS NS
1.435  1.173 80 20 NS NS
1.247  1.16 90 10 NS NS
0.778  1.067 80 20 0.1 NS NS
1.813  1.131 90 10 0.1 NS NS
3.058  1.218 80 20 0.1 NS NS
4.197  1.247 90 10 0.1 NS NS
1.289  1.198 50 0.2 50 NS NS
1.123  1.095 70 30 NS NS
8 1.141  1.053 80 20 0.1 NS NS
3.018  1.224 80 20 NS NS
4.758  1.282 90 10 NS NS
3.397  1.292 80 20 0.1 NS NS
5.268  1.293 90 10 0.1 NS NS
9 2.503  1.242 80 20 0.1 NS NS
1.964  1.281 60 40 0.1 NS NS
10 4.116  1.372 80 20 NS NS
3.74  1.672 70 30 NS NS
4.65  1.454 80 20 0.1 NS NS
2.528  1.399 60 40 0.1 NS NS
2.615  1.772 80 20 NS NS
11  1.248 1.28 60 40 NS NS
12 1.14  1.104 80 20 0.1 NS NS
0.671  1.604 80 20 0.1 NS NS
0.891  1.041 90 10 0.1 NS NS
13  5.136 2.121 2 98 6.94 3.429
14  3.327 1.286 80 20 0.1 NS NS
16 0.415  1.123 80 20 NS NS
0.648  1.104 70 30 NS NS
0.737  1.132 80 20 0.1 NS NS
5.02  1.152 60 40 0.1 NS NS
1.677  1.101 90 10 NS NS
1.338  1.083 80 20 0.1 NS NS
2.369  1.119 90 10 0.1 NS NS
0.944  1.188 80 20 0.1 NS NS
1.084  1.149 80 20 NS NS
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Table 1 (Continued)
IG Normal solvents Additives IA
Standard solvents Nonstandard solvents
Rs  n-Hexane 2-PrOH EtOH THF DCM MtBE TEA TFA Rs 
2.392 1.518 60 40 NS NS
17 0.711 1.041 90 10 NS NS
4.556  1.699 80 20 NS NS
5.138  1.571 70 30 NS NS
8.887  2.012 80 20 0.1 NS NS
7.984  2.194 60 40 0.1 NS NS
9.048  1.636 90 10 NS NS
10.642  1.881 80 20 0.1 NS NS
0.879  1.15 90 10 0.1 NS NS
1.809  1.126 70 30 NS NS
18 2.787 1.321 90 10 1.645 1.114
1.972  1.108 90 10 0.1 NS NS
7.2  1.907 90 10 15.614 2.32
8.423  1.462 80 20 0.1 NS NS
10.05  1.597 90 10 0.1 NS NS
8.214  1.533 80 20 0.1 NS NS
9.967  1.595 90 10 0.1 NS NS
4.724  1.673 2 98 1.51 1.468
2.354  1.652 60 40 NS NS
19 1.453 1.115 90 10 0.599 1.17
2.656  1.159 80 20 NS NS
1.191  1.142 70 30 NS NS
1.323  1.126 90 10 0.1 NS NS
1.329  1.16 80 20 0.1 NS NS
0.985  1.146 70 30 0.1 NS NS
14.749  2.029 80 20 NS NS
15.026  2.304 80 20 0.1 NS NS
15.536  2.022 80 20 0.1 NS NS
1.919  1.141 70 30 NS NS
1.958  1.147 80 20 NS NS
4.038  1.231 50 0.2 50 NS NS
7.971  3.784 2 98 0.947 1.32
3.098  2.544 60 40 NS NS
25 1.039 1.031 90 10 1.516 1.092
1.14  1.203 80 20 NS NS
0.99  1.202 70 30 NS NS
3.244  1.18 90 10 0.1 NS NS
2.519  1.217 80 20 0.1 NS NS
1.708  1.274 70 30 0.1 NS NS
1.334  1.18 60 40 0.1 NS NS
1.306  1.101 80 20 NS NS
1.68  1.095 90 10 1.041 1.071
1.328  1.103 80 20 0.1 NS NS
1.619  1.091 90 10 0.1 NS NS
1.116  1.082 80 20 0.1 NS NS
1.711  1.098 90 10 0.1 NS NS
0.661  1.066 60 40 NS NS
1.87  1.128 80 20 NS NS
1.538  1.126 50 0.2 50 NS NS
1.324  1.332 2 98 NS NS
26 5.505 1.493 80 20 0.1 NS NS
3.242  1.309 80 20 0.1 NS NS
5.075  1.665 90 10 0.1 NS NS
27 1.195 1.035 90 10 1.896 1.137
1.107  1.291 80 20 NS NS
1  1.29 70 30 NS NS
1.441  1.085 90 10 0.1 NS NS
0.971  1.065 80 20 0.1 NS NS
0.886  1.029 70 30 0.1 NS NS
0.722  1.037 60 40 0.1 NS NS
1.371  1.119 80 20
2.068 1.123 90 10 1.658 1.133
1.271  1.114 80 20 0.1 NS NS
2.098  1.125 90 10 0.1 NS NS
1.133  1.095 80 20 0.1 NS NS
2.081  1.078 90 10 0.1 NS NS
1.324  1.113 80 20 NS NS
2.039  1.193 50 0.2 50 NS NS
NS  NS 2 98 0.687 1.175
28 NS  NS 90 10 0.906 1.106
0.621  1.137 80 20 NS NS
1.202  1.152 90 10 NS NS
0.711  1.12 80 20 0.1 NS NS
0.278  1.12 80 20 0.1 NS NS
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Table  2
The resolution Rs and separation factor  for the enantioselective separation of racemates under reversed mobile phase condition.
Reversedmobilephase
IG IA
Rs  ACN/H2O/0.1TEA Rs 
2 NS NS 60/40 1.429 1.097
4 16.801 2.637 60/40 NS NS
12.384  2.719 80/20 NS NS
8  5.831 1.461 60/40 NS NS
12  1.325 1.179 60/40 NS NS
13  NS NS 60/40 2.275 1.285
14 0.965 1.084 60/40 NS NS
1.1  1.071 80/20 NS NS
16 1.443 1.09 60/40 NS NS
1.496  1.109 80/20 NS NS
17 4.549 1.399 60/40 NS NS
4.216  1.385 80/20 NS NS
18  NS NS 60/40 10.91 1.678
19 11.174 2.965 40/60 NS NS
7.721  3.214 60/40 5.563 2.822
5.825  2.441 80/20 NS NS
25  1.125 1.055 40/60 NS NS
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w26  1.117 1.247 
27 1.897 1.133 
0.906  1.07 
on-standard organic solvent (MtBE 98% v) in combination with
thanol (EtOH 2% v) or MtBE/EtOH 98:2 v/v, respectively with res-
lution Rs 5.13 and separation factor  2.12. Similarly compound
3 was only separated under non-standard organic mobile phase
omposition consisting of MtBE/EtOH 98:2 v/v. Better separations
ere achieved in non-standard solvents when compared to simi-
ar separation under standard organic solvents for compounds 3, 6
nd 16 (Table 1 and Fig. 3). One can conclude that polarity plays
 role in the chiral recognition of CHIRALPAK IG
®
. For example,
thanol with polarity index 5.2 works well in combination with n-
exane or MtBE while 2-PrOH with polarity index 3.9 is less sensible
n terms of enantioseparation under standard and non-standard
rganic solvents. Another factor might be the amendment of the
tereo environment of the chiral cavities in amylose derivatives is
avourable in presence of ethanol for the enantioseparation of the
nvestigated racemates.
.2. Chiral separation under reversed phase
Although the use of reversed phase in amylose and cellulose-
ased as CSPs in enantioselective liquid chromatography is limited,
here are few recently reported studies [22,34–39]. The choice of
eversed phase was based on its economic and environmental ben-
ﬁts. Thus, the enantioselective separation was investigated using
eversed phases including acetonitrile (ACN) and water (H2O) mix-
ure ranging from 10–90% (v/v) (Table 2 and Fig. 4). Few baseline
eparations were achieved under acetonitrile condition for com-
ounds 4, 8, 12,  14,  16,  17,  19,  25,  26 and 27.  Of particular interest
ompound 4 was baseline separated with unpreceded resolution
f Rs 16.80 and separation factor  2.63 under ACN/H2O 60:40 v/v
n presence of 0.1% TEA in mobile phase composition. Similarly,
n case of 8; Rs 5.83 and separation factor  1.46 were superior
o other separations achieved under standard and non-standard
rganic solvents (Table 2 and Fig. 4). Compound 12 which was  mod-
rately separated under standard and non-standard solvents, was
aseline separated under reversed phase condition (ACN/H2O/TEA
0:40:0.1% v/v) with superior Rs 1.35 and  1.46.
.3. Methyl vs chlorine substituent in CHIRALPAK IA
®
vs
HIRALPAK IG
®
In an attempt to study the effect of the introduction of the
ithdrawing chlorine group instead of donating methyl group in60/40 NS NS
40/60 NS NS
60/40 NS NS
the third position of amylose tris (3,5-dimethylphenylcarbamate)
or ADMPC known as CHIRALAPAK IA
®
to make the amylose tris
(3-chloro-5-methylphenylcarbamate) known as CHIRALPAK IG
®
, a
brief comparison between CHIRALPAK IA
®
vs CHIRALPAK IG
®
took
place under standard, non-standard and reversed phase mobile
phase composition for the enantioselective separation of selected
racemates (Fig. 2). As previously demonstrated above, in terms of
the resolution Rs and separation factor , n-hexane/EtOH 90:10 v/v
mixture was  the best performing mixture of standard solvents in
mobile phase composition. This mobile phase mixture was  cho-
sen in the comparison study for the enantioselective resolution of
racemates under CHIRALPAK IA
®
. Comparing with CHIRALPAK IG
®
,
under similar condition, only compounds 2 (Rs 0.31,  1.11), 18
(Rs 15.61,  2.32), 25 (Rs 1.04,  1.07) and 27 (Rs 1.65,  1.13)
were partially or base-line separated under n-hexane/EtOH 90:10
v/v mobile phase. Moving to n-hexane/2-PrOH 90:10 v/v instead of
n-hexane/EtOH 90:10 v/v in mobile phase composition resulted in
the partial or base-line separation of 18 (Rs 1.64,  1.11), 19 (Rs
0.59,  1.17), 25 (Rs 1.51,  1.09), 27 (Rs 1.89,  1.13) and 28 (Rs
0.90,  1.10). In terms of resolution Rs and separation factor ,
CHIRALPAK IG
®
was superior than CHIRALPAK IA
®
when operat-
ing under n-hexane/EtOH 90:10 v/v or n-hexane/2-PrOH 90:10 v/v
in mobile phase composition. When using non-standard solvent in
excess in mobile phase composition e.g.  n-hexane/MtBE 2/98% v/v,
only two  compounds were separated on CHIRALPAK IA
®
namely
compounds 18 (Rs 1.51,  1.46) and 27 (Rs 0.68,  1.17). Moving to
MtBE/EtOH 98/2% v/v, only four compounds were separated under
CHIRALPAK IA
®
namely 13,  18,  19 and 26 comparing to seven com-
pounds separated under CHIRALPAK IG
®
(3, 5, 6, 13, 18,  19,  25 and
26). It is noteworthy that the resolution Rs and separation factor
 were all better on CHIRALPAK IG
®
(Table 1). The results align
with previous ﬁnding about the chiral recognition of the regios-
elective substituted polysaccharide derivatives [8]. The different
chiral recognition abilities may  be ascribed to the electronic effect
of substituents namely the withdrawing chlorine group versus the
donating methyl group which in turn can alter the polarity and the
3D structure of the polymer.
Under reversed mobile phase composition namely
ACN/H2O/TEA 60:40:0.1 v/v/v respectively, only compounds 2
(Rs 1.42,  1.09), 13 (Rs 2.27,  1.28), 18 (Rs 10.91,  1.67), and
19 (Rs 5.56,  2.82) were baseline separated on CHIRALPAK IA
®
comparing to compounds 4, 8, 12,  14,  16,  17,  19,  25,  26,  and 27
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[Fig. 4. UV traces/Chromatograms for the enantioselective s
eparated on CHIRALPAK IG
®
. It is noteworthy to mention that
ompounds 2, 13,  18 were not previously separated on CHIRALPAK
G
®
under similar conditions (Table 2).
The enantioselective separation under non-standard solvents’
obile phase revealed that the combination of n-hexane with MtBE
orks best where ten compounds (3, 5, 6, 11,  13,  16,  18,  19,  25 and
7) were separated comparing with n-hexane/THF with eight com-
ounds separated (3, 4, 5, 16,  17,  19,  25 and 27)  and n-hexane/DCM
ith only four compunds separated (4, 7, 25 and 27).
. Conclusions
The solvents versatility of CHIRALPAK IG
®
has been demon-
trated. The results revealed that solvents known as prohibited
on-standard LC solvents such as MtBE, DCM and THF in which
he amylose derivatives CSP can be dissolved/swollen can be used
s eluents in mobile phase compositions. The addition of these
olvents will be also beneﬁcial when used as diluents to directly
onitor organic reactions online. Several tested racemates that
ere not separable under normal standard organic solvents were
eparated under non-standard organic solvents in mobile phase
omposition. The use of reversed phase consisting of ACN/H2O
roaden the application of CHIRALPAK IG
®
with enhanced reso-
ution Rs and separation factor  comparing to similar separation
nder standard and non-standard organic solvents. Compared with
HIRALPAK IA
®
and in terms of resolution Rs and separation factor
, CHIRALPAK IG
®
appears to be superior under standard and non-
tandard solvents for the tested compounds. Overall, for the tested
ompounds, CHIRALPAK IG
®
appears to be superior to CHIRALPAK
A
®
and it may  offer an alternative to CHIRALPAK IA
®
.
eferences
[1] V. Schurig, The reciprocal principle of selectand-selector-systems in
supramolecular chromatography, Molecules 21 (11) (2016) 1535.
[2] I. Ali, H.Y. Aboul-Enein, Chiral Pollutants: Distribution, Toxicity and Analysis
by Chromatography and Capillary Electrophoresis, John Wiley & Sons, 2005.
[3] A.A. Younes, D. Mangelings, Y. Vander Heyden, Chiral separations in
reversed-phase liquid chromatography: evaluation of several
polysaccharide-based chiral stationary phases for a separation strategy
update, J. Chromatogr. A 1269 (2012) 154–167.
[4] E.R. Francotte, Enantioselective chromatography as a powerful alternative for
the preparation of drug enantiomers, J. Chromatogr. A 906 (1) (2001)
379–397.
[tion of racemates under reversed mobile phase (ACN/H2O).
[5] E. Gil-Av, B. Feibush, Resolution of enantiomers by gas liquid chromatography
with optically active stationary phases. Separation on packed columns,
Tetrahedron Lett. 8 (35) (1967) 3345–3347.
[6] S.M. Han, Direct enantiomeric separations by high performance liquid
chromatography using cyclodextrins, Biomed. Chromatogr. 11 (5) (1997)
259–271.
[7] T. Zhang, et al., Complementary enantiorecognition patterns and speciﬁc
method optimization aspects on immobilized polysaccharide-derived chiral
stationary phases, J. Chromatogr. A 1269 (2012) 178–188.
[8] S. Tang, et al., Preparation and evaluation of regioselectively substituted
amylose derivatives for chiral separations, Chirality (2017), in press.
[9] S. Fanali, Nano-liquid chromatography applied to enantiomers separation, J.
Chromatogr. A 1486 (2017) 20–34.
10] D. Sadutto, et al., Analytical and semipreparative high performance liquid
chromatography enantioseparation of bicalutamide and its chiral impurities
on  an immobilized polysaccharide-based chiral stationary phase, J.
Chromatogr. A 1445 (2016) 166–171.
11] E. Francotte, T. Zhang, Preparation and evaluation of immobilized
4-methylbenzoylcellulose stationary phases for enantioselective separations,
J.  Chromatogr. A 1467 (2016) 214–220.
12] Y. Okamoto, M. Kawashima, K. Hatada, Chromatographic resolution: XI.
Controlled chiral recognition of cellulose triphenylcarbamate derivatives
supported on silica gel, J. Chromatogr. A 363 (2) (1986) 173–186.
13] P. Peluso, V. Mamane, S. Cossu, Liquid chromatography enantioseparations of
halogenated compounds on polysaccharide-based chiral stationary phases:
role of halogen substituents in molecular recognition, Chirality 27 (10) (2015)
667–684.
14] O. Kurka, L. Kucˇera, P. Bednárˇ, Analytical and semipreparative chiral
separation of cis-itraconazole on cellulose stationary phases by
high-performance liquid chromatography, J. Sep. Sci. 39 (14) (2016)
2736–2745.
15] J. Shen, T. Ikai, Y. Okamoto, Synthesis and application of immobilized
polysaccharide-based chiral stationary phases for enantioseparation by
high-performance liquid chromatography, J. Chromatogr. A 1363 (2014)
51–61.
16] L. Bezhitashvili, et al., Effect of pore-size optimization on the performance of
polysaccharide-based superﬁcially porous chiral stationary phases for the
separation of enantiomers in high-performance liquid chromatography, J.
Chromatogr. A 1482 (2017) 32–38.
17] J. Shen, Y. Okamoto, Efﬁcient separation of enantiomers using stereoregular
chiral polymers, Chem. Rev. 116 (3) (2015) 1094–1138.
18] Y. Kaida, Y. Okamoto, Optical resolution on regioselectively carbamoylated
cellulose and amylose with 3, 5-dimethylphenyl and 3, 5-dichlorophenyl
isocyanates, Bull. Chem. Soc. Jpn. 66 (8) (1993) 2225–2232.
19] B. Chankvetadze, et al., High-performance liquid chromatographic
enantioseparations on capillary columns containing crosslinked
polysaccharide phenylcarbamate derivatives attached to monolithic silica, J.
Sep. Sci. 29 (13) (2006) 1988–1995.
20] J. Ou, et al., Hybrid monolithic columns coated with cellulose tris (3,
5-dimethylphenyl-carbamate) for enantioseparations in capillary
electrochromatography and capillary liquid chromatography, J. Chromatogr.
A  1269 (2012) 372–378.21] M.  Ahmed, M. Gwairgi, A. Ghanem, Conventional Chiralpak ID vs. Capillary
Chiralpak ID-3 amylose tris-(3-chlorophenylcarbamate)-based chiral
stationary phase columns for the enantioselective HPLC separation of
pharmaceutical racemates, Chirality 26 (11) (2014) 677–682.
romat
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
ﬂavanone, naringenin, and Hesperetin enantiomers by RP-UHPLC-DAD,
Chirality 28 (2) (2016) 147–152.A. Ghanem, C. Wang / J. Ch
22] C. Fanali, S. Fanali, B. Chankvetadze, HPLC separation of enantiomers of some
ﬂavanone derivatives using polysaccharide-based chiral selectors covalently
immobilized on silica, Chromatographia 79 (3-4) (2016) 119–124.
23] A. Ghanem, et al., Immobilized -cyclodextrin-based silica vs polymer
monoliths for chiral nano liquid chromatographic separation of racemates,
Talanta 132 (2015) 301–314.
24] B. Sun, et al., Preparation of regioselectively modiﬁed amylose derivatives and
their applications in chiral HPLC, Chromatographia 75 (23-24) (2012)
1347–1354.
25] S. Rocchi, et al., Effect of content of chiral selector and pore size of core–shell
type silica support on the performance of amylose tris (3,
5-dimethylphenylcarbamate)-based chiral stationary phases in nano-liquid
chromatography and capillary electrochromatography, J. Chromatogr. A 1363
(2014) 363–371.
26] R. Cirilli, et al., Unusually high enantioselectivity in high-performance liquid
chromatography using cellulose tris (4-methylbenzoate) as a chiral stationary
phase, J. Chromatogr. A 1216 (22) (2009) 4673–4678.
27] A. Ghanem, et al., Solvent versatility of immobilized amylose and
cellulose-based chiral stationary phases in enantioselective LC separation and
monitoring of bio-catalyzed resolutions of acidic drugs in non-standard
organic solvents, Chromatographia 70 (3-4) (2009) 349–363.
28] A. Ghanem, E. Al-Humaidi, Chiral recognition ability and solvent versatility of
bonded amylose tris (3, 5-dimethylphenylcarbamate) chiral stationary phase:
enantioselective liquid chromatographic resolution of racemic N-alkylated
barbiturates and thalidomide analogs, Chirality 19 (6) (2007) 477–484.
29] I. Ali, et al., Chiral separations of piperidine-2, 6-dione analogues on Chiralpak
IA and Chiralpak IB columns by using HPLC, Talanta 69 (4) (2006) 1013–1017.
30] A. Ghanem, H. Hoenen, H.Y. Aboul-Enein, Application and comparison of
immobilized and coated amylose tris-(3, 5-dimethylphenylcarbamate) chiral
stationary phases for the enantioselective separation of -blockers
enantiomers by liquid chromatography, Talanta 68 (3) (2006) 602–609.
31] A. Ghanem, L. Naim, Immobilized versus coated amylose tris (3,
5-dimethylphenylcarbamate) chiral stationary phases for the
[ogr. A 1532 (2018) 89–97 97
enantioselective separation of cyclopropane derivatives by liquid
chromatography, J. Chromatogr. A 1101 (1) (2006) 171–178.
32] A. Ghanem, H.Y. Aboul-Enein, Comparison, applications, advantages, and
limitations of immobilized and coated amylose tris-(3,
5-Dimethylphenylcarbamate) chiral stationary phases in HPLC, J. Liq.
Chromatogr. Relat. Technol. 28 (17) (2005) 2669–2680.
33] R. Cirilli, et al., The sodium salt of the enantiomers of ricobendazole:
preparation, solubility and chiroptical properties, J. Pharm. Biomed. Anal. 139
(2017) 1–7.
34] S. Magiera, W.  Adolf, I. Baranowska, Simultaneous chiral separation and
determination of carvedilol and 5′-hydroxyphenyl carvedilol enantiomers
from human urine by high performance liquid chromatography coupled with
ﬂuorescent detection, Open Chem. 11 (12) (2013) 2076–2087.
35] S. Magiera, E. Kwietniowska, Fast, simple and efﬁcient salting-out assisted
liquid-liquid extraction of naringenin from fruit juice samples prior to their
enantioselective determination by liquid chromatography, Food Chem. 211
(2016) 227–234.
36] I. Baranowska, J. Hejniak, S. Magiera, Development and validation of a
RP-UHPLC-ESI-MS/MS method for the chiral separation and determination of
ﬂavanone, naringenin and hesperetin enantiomers, Talanta 159 (2016)
181–188.
37] I. Baranowska, W.  Adolf, S. Magiera, Enantioselective determination of
metoprolol and its metabolites in human urine high-performance liquid
chromatography with ﬂuorescence detection (HPLC–FLD) and tandem mass
spectrometry (MS/MS), J. Chromatogr. B 1004 (2015) 79–84.
38] I. Baranowska, J. Hejniak, S. Magiera, Simultaneous chiral separation of39] S. Magiera, A. Piwowarczyk, A. We˛grzyn, A study of the enantiospeciﬁc
degradation of ibuprofen in model aqueous samples using LLME-HPLC-DAD,
Anal. Methods 8 (43) (2016) 7789–7799.
